Home> News> Presenting Multiple Myeloma sub-projects at EMN2024

Presenting Multiple Myeloma sub-projects at EMN2024

April 20, 2024 16:03 - x 00, 0 - 00:00

#bigdataforbloodcancer, Myeloma

We participated in the 5th meeting of the European Myeloma Network – EMN2024, in Turin, Italy, from 18 to 20 April 2024.

Our joint EMN-HARMONY session took place on 19 April 2024. HARMONY Alliance Partners presented about 2 sub-projects in the framework of the RISS in the HARMONY Multiple Myeloma (MM) project and about synthetic data in MM.

The theme of our joint EMN-HARMONY session program was data-driven research in Multiple Myeloma, and presenting were:

Pieter Sonneveld, EMN President, EHA SWG on Multiple Myeloma Chair, HARMONY Alliance Foundation Advisory Board Member about the opportunities of data innovation in Multiple Myeloma, the continued EMN-HARMONY collaboration and about the developments after the EU funded period.

Elias K. Mai, Heidelberg University Hospital, HARMONY Alliance Partner about Identification of predictors for early MM disease progression and long-term survivors.

Adrián Mosquera Orgueira, University Hospital of Santiago de Compostela, HARMONY Alliance Partner about Enhancing Multiple Myeloma Risk Stratification through Machine Learning Integration with the HARMONY Database.

Gastone Castellani, University of Bologna, HARMONY Alliance Partner about Synthetic data for accelerating translational research and clinical application in Multiple Myeloma.

For more information about the HARMONY MM Research Project: Revised International Staging System for Multiple Myeloma: Extended follow-up in the European clinical trial population and evaluation of the efficacy of different novel agents and treatment approaches in subsets of patients with standard- and high-risk features, click here >.

Would you like to connect about the topics with our MM Partners, please send an email to e.dewaal@ehaweb.org.

For an overview of all HARMONY Research Projects, click here >.

It was extremely valuable to reconnect with the EMN Community and to update about the HARMONY Alliance developments of the past 7 years. The HARMONY Alliance would like to thank EMN for this opportunity.

This is the link to the EMN2024 website >.

Receive the latest news. Click here to subscribe!

Public-private partnership for Big Data in Hematology

HARMONY and HARMONY PLUS are funded through the Innovative Medicines Initiative (IMI), Europe's largest public-private initiative aiming to speed up the development of better and safer medicines for patients. Funding is received from the IMI 2 Joint Undertaking and is listed under grant agreement for HARMONY No. 116026 and grant agreement for HARMONY PLUS No. 945406. This Joint Undertaking receives support from the European Union’s Horizon 2020 Research and Innovation Programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA).